ADMA Biologics
Biotechnology Research • 
Ramsey, New Jersey, United States • 201-500 Employees
Company overview
| Headquarters | 465 Route 17 South, Ramsey, NJ 07446, US |
| Phone number | +12014785552 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Infectious Disease, Biologics, Pharmaceutical Manufacturing, Plasma Products, Plasma Collection, Immune Deficiency |
| Founded | 2004 |
| Employees | 201-500 |
| Socials |
Key Contacts at ADMA Biologics
Marie-Chantale Simard
Director Medical Affairs
Jennifer Kelley
Associate Director Of Hr
Young Kwon
Board Of Directors
John Hafl
Executive Director Of Sales
Dwain Saylor
Associate Director Facilities & Maintenance
Claire Hennessy
Regional Business Director Northeast
Sondra Barcelo
National Acute Care Director
Ricardo Carneiro
Executive Director, Market Access & Reimbursement
Melissa Kohler
Director Of Quality Control
Nick Singleton
Sr. Director, Operations
ADMA Biologics Email Formats
ADMA Biologics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@admabio.com), used 55.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@admabio.com | 55.6% |
{last name}{last name} | doedoe@admabio.com | 41.3% |
{2char} | {2char}@admabio.com | 3.2% |
About ADMA Biologics
ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
ADMA Biologics revenue & valuation
| Annual revenue | $474,200,000 |
| Revenue per employee | $1,132,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,517,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
ADMA Biologics has 190 employees across 14 departments.
Departments
Number of employees
Funding Data
ADMA Biologics has never raised funding before.
ADMA Biologics Tech Stack
Discover the technologies and tools that power ADMA Biologics's digital infrastructure, from frameworks to analytics platforms.
Security
CMS
JavaScript libraries
JavaScript libraries
Reverse proxies
CDN
JavaScript libraries
Analytics
Miscellaneous
Security
Analytics
Tag managers
Kenya
South Africa
Spain
Taiwan, Province of ChinaFrequently asked questions
4.8
40,000 users
